The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
The dark side of C5a in sepsis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird, W. C. (2003) · Blood · doi:10.1182/blood-2002-06-1887 · Cited by 1,131
Sacks, T., Moldow, C. F., Craddock, P. R., Bowers, T. K., & Jacob, H. S. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109031 · Cited by 1,103
Waage, A., Halstensen, A., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,096
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6952 · Cited by 934
Serum Cytokine Levels in Human Septic Shock
Pinsky, M. R., Vincent, J.-L., Deviere, J., Alegre, M., Kahn, R. J., & Dupont, E. (1993) · Chest · doi:10.1378/chest.103.2.565 · Cited by 884
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Bustin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5237 · Cited by 845
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Self-citationCirculating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Stanford, G. G., van der Meer, J. W. M., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.1.79 · Cited by 751
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., & Suffredini, A. F. (2003) · Blood · doi:10.1182/blood-2002-05-1300 · Cited by 737
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
Sarnak, M. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00337.x · Cited by 723
The chemotactic receptor for human C5a anaphylatoxin
Gerard, N. P., & Gerard, C. (1991) · Nature · doi:10.1038/349614a0 · Cited by 655
Schlesinger, L. S., Bellinger-Kawahara, C. G., Payne, N. R., & Horwitz, M. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.7.2771 · Cited by 539
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
Hotchkiss, R. S., Chang, K. C., Swanson, P. E., Tinsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., et al. (2000) · Nature Immunology · doi:10.1038/82741 · Cited by 526
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
Chenoweth, D. E., & Hugli, T. E. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3943 · Cited by 509
Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L., & Carroll, M. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11490 · Cited by 503
C5a-induced expression of P-selectin in endothelial cells.
Foreman, K. E., Vaporciyan, A. A., Bonish, B. K., Jones, M. L., Johnson, K. J., Glovsky, M. M., Eddy, S. M., & Ward, P. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117430 · Cited by 473
Self-citationMollnes, T. E., Brekke, O., Fung, M. S. C., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegård, K. T., Köhl, J., & Lambris, J. D. (2002) · PubMed · doi:10.1182/blood.v100.5.1869.h81702001869_1869_1877 · Cited by 455
Protective effects of C5a blockade in sepsis
Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., & Ward, P. A. (1999) · Nature Medicine · doi:10.1038/10512 · Cited by 404
Self-citationClynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T., & Ravetch, J. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.179 · Cited by 387
Definitions for sepsis and organ failure
Bone, R. C. (1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00002 · Cited by 360
Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Self-citationAnti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 288
Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors.
Payne, N. R., & Horwitz, M. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1377 · Cited by 282
Chemotactic and Anaphylatoxic Fragment Cleaved from the Fifth Component of Guinea Pig Complement
Shin, H. S., Snyderman, R., Friedman, E., Mellors, A., & Mayer, M. M. (1968) · Science · doi:10.1126/science.162.3851.361 · Cited by 281
C5a Induces Tissue Factor Activity on Endothelial Cells
Ikeda, K., Nagasawa, K., Horiuchi, T., Tsuru, T., Nishizaka, H., & Niho, Y. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655974 · Cited by 272
Dhainaut, J.-F. A., Tenaillon, A., Le Tulzo, Y., Schlemmer, B., Solet, J.-P., Wolff, M., Holzapfel, L., Zeni, F., Dreyfuss, D., Mira, J.-P., et al. (1994) · Critical Care Medicine · doi:10.1097/00003246-199411000-00005 · Cited by 269
Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.
Stevens, J. H., O'Hanley, P. D., Shapiro, J., Mihm, F. G., Satoh, P. S., Collins, J. A., & Raffin, T. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112506 · Cited by 267
G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells.
Amatruda, T. T., Steele, D. A., Slepak, V. Z., & Simon, M. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5587 · Cited by 265
Cytokine-induced neutrophil-derived interleukin-8.
Strieter, R. M., Kasahara, K., Allen, R., Standiford, T. J., Rolfe, M. W., Becker, F. S., Chensue, S. W., & Kunkel, S. L. (1992) · PubMed Central · Cited by 253
MONSINJON, T., GASQUE, P., CHAN, P., ISCHENKO, A., BRADY, J. J., & FONTAINE, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0737com · Cited by 249
Haviland, D. L., McCoy, R. L., Whitehead, W. T., Akama, H., Molmenti, E. P., Brown, A., Haviland, J. C., Parks, W. C., Perlmutter, D. H., & Wetsel, R. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1861 · Cited by 247
Siciliano, S. J., Rollins, T. E., DeMartino, J., Konteatis, Z., Malkowitz, L., Van Riper, G., Bondy, S., Rosen, H., & Springer, M. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1214 · Cited by 233
Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells
Schraufstatter, I. U., Trieu, K., Sikora, L., Sriramarao, P., & DiScipio, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2102 · Cited by 233
The role of complement in inflammation and adaptive immunity
Barrington, R., Zhang, M., Fischer, M., & Carroll, M. C. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800101.x · Cited by 232
Clinical Trials of Immunomodulatory Therapies in Severe Sepsis and Septic Shock
Vincent, J., Sun, Q., & Dubois, M. (2002) · Clinical Infectious Diseases · doi:10.1086/339549 · Cited by 228
Role of C5a in Multiorgan Failure During Sepsis
Huber-Lang, M., Sarma, V. J., Lu, K. T., McGuire, S. R., Padgaonkar, V. A., Guo, R.-F., Younkin, E. M., Kunkel, R. G., Ding, J., Erickson, R., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1193 · Cited by 224
Self-citationMARTY, C., MISSET, B., TAMION, F., FITTING, C., CARLET, J., & CAVAILLON, J.-M. (1994) · Critical Care Medicine · doi:10.1097/00003246-199404000-00025 · Cited by 212
Generation of C5a by Phagocytic Cells
Huber-Lang, M., Younkin, E. M., Sarma, J. V., Riedemann, N., McGuire, S. R., Lu, K. T., Kunkel, R., Younger, J. G., Zetoune, F. S., & Ward, P. A. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64461-6 · Cited by 212
Self-citationImmunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
Sylvestre, D., Clynes, R., Ma, M., Warren, H., Carroll, M. C., & Ravetch, J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2385 · Cited by 202
Complement-Induced Impairment of Innate Immunity During Sepsis
Huber-Lang, M. S., Younkin, E. M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Curnutte, J. T., Erickson, R., & Ward, P. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3223 · Cited by 200
Self-citationComplement Activation and Endotoxin Levels in Systemic Meningococcal Disease
Brandtzaeg, P., Mollnes, T. E., & Kierulf, P. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/160.1.58 · Cited by 197
Generation of C5-Derived Lysosomal Enzyme-Releasing Activity (C5a) by Lysates of Leukocyte Lysosomes
Goldstein, I. M., & Weissmann, G. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.113.5.1583 · Cited by 194
Marder, S. R., Chenoweth, D. E., Goldstein, I. M., & Perez, H. D. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.5.3325 · Cited by 190
Increased C5a receptor expression in sepsis
Riedemann, N. C., Guo, R., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D. C., Strey, C. W., Pierson, C. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15409 · Cited by 190
Self-citationExpression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells
Laudes, I. J., Chu, J. C., Huber-Lang, M., Guo, R.-F., Riedemann, N. C., Sarma, J. V., Mahdi, F., Murphy, H. S., Speyer, C., Lu, K. T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5962 · Cited by 181
Self-citationEndotoxin-induced shock in the rat. A role for C5a.
SMEDEGÅRD, G., Cui, L., & Hugli, T. E. (1989) · PubMed · Cited by 179
Spies, C. D., Reinhart, K., Witt, I., Meier-Hellmann, A., Hannemann, L., Bredle, D. L., & Schaffartzik, W. (1994) · Critical Care Medicine · doi:10.1097/00003246-199411000-00007 · Cited by 170
Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of Sepsis
Laudes, I. J., Chu, J. C., Sikranth, S., Huber-Lang, M., Guo, R.-F., Riedemann, N., Sarma, J. V., Schmaier, A. H., & Ward, P. A. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61133-9 · Cited by 165
Self-citationTomhave, E. D., Richardson, R. M., Didsbury, J. R., Menard, L., Snyderman, R., & Ali, H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.7.3267 · Cited by 164
Protection of innate immunity by C5aR antagonist in septic mice
Huber‐Lang, M. S., Riedeman, N. C., Sarma, J. V., Younkin, E. M., McGuire, S. R., Laudes, I. J., Lu, K. T., Guo, R., Neff, T. A., Padgaonkar, V. A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0209com · Cited by 161
Self-citationKilgore, K. S., Flory, C. M., Miller, B. F., Evans, V. M., & Warren, J. S. (1996) · Europe PMC (PubMed Central) · Cited by 160
Role for the Alternative Complement Pathway in Ischemia/Reperfusion Injury
Stahl, G. L., Xu, Y., Hao, L., Miller, M., Buras, J. A., Fung, M., & Zhao, H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63839-4 · Cited by 160
YU, M., & TOMASA, G. (1993) · Critical Care Medicine · doi:10.1097/00003246-199311000-00010 · Cited by 158
Increased C5a receptor expression in sepsis
Riedemann, N. C., Guo, R., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D. C., Strey, C. W., Pierson, C. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215409 · Cited by 157
Self-citationDhainaut, J.-F., Tenaillon, A., Hemmer, M., Damas, P., Tulzo, Y. L., Radermacher, P., Schaller, M., Sollet, J.-P., Wolff, M., Holzapfel, L., et al. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00021 · Cited by 153
Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis
Guo, R., Huber-Lang, M. S., Wang, X., Sarma, V. J., Padgaonkar, V. A., Craig, R. A., Riedemann, N. C., McClintock, S. D., Hlaing, T., Shi, M. M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10793 · Cited by 152
Self-citationMacrophage Migration Inhibitory Factor (MIF)
Nishihira, J., Ishibashi, T., Fukushima, T., Sun, B., Sato, Y., & Todo, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03220.x · Cited by 138
Pertussis Toxin-sensitive Activation of Phospholipase C by the C5a and fMet-Leu-Phe Receptors
Jiang, H., Kuang, Y., Wu, Y., Smrcka, A. V., Simon, M. I., & Wu, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13430 · Cited by 137
The acute phase protein response in patients receiving subcutaneous IL-6
Banks, R. E., Forbes, M. A., Storr, M., Higginson, J., Thompson, D., Raynes, J. G., Illingworth, J. M., Perren, T. J., Selby, P. J., & Whicher, J. T. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06659.x · Cited by 130
Solomkin, J. S., Jenkins, M. K., Nelson, R. D., Chenoweth, D. E., & Simmons, R. L. (1981) · PubMed · Cited by 129
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway
Perianayagam, M. C., Balakrishnan, V. S., King, A. J., Pereira, B. J. G., & Jaber, B. L. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00139.x · Cited by 123
Regulation by C5a of Neutrophil Activation during Sepsis
Riedemann, N. C., Guo, R., Bernacki, K. D., Reuben, J. S., Laudes, I. J., Neff, T. A., Gao, H., Speyer, C. L., Sarma, V. J., Zetoune, F. S., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00206-1 · Cited by 121
Self-citationProlonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study
Avontuur, J. A. M., Nolthenius, R. P. T., van Bodegom, J. W., & Bruining, H. A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00012 · Cited by 120
Expression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells
Riedemann, N. C., Guo, R., Sarma, V. J., Laudes, I. J., Huber-Lang, M. S., Warner, R. L., Albrecht, E. A., Speyer, C. L., & Ward, P. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1919 · Cited by 104
Self-citationRoles of phospholipid signaling in chemoattractant-induced responses
Wu, D., Huang, C., & Jiang, H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.17.2935 · Cited by 100
Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome
Stöve, S., Welte, T., Wagner, T., Kola, A., Klos, A., Bautsch, W., & Köhl, J. (1996) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.3.2.175-183.1996 · Cited by 96
Jagels, M. A., Daffern, P. J., & Hugli, T. E. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(99)00178-2 · Cited by 95
Complement C5a in the Sepsis Syndrome — Too Much of a Good Thing?
Gerard, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr022995 · Cited by 88
C5a receptor and thymocyte apoptosis in sepsis
Riedemann, N. C., Guo, R., Laudes, I. J., Keller, K. A., Sarma, V. J., Padgaonkar, V. A., Zetoune, F. S., & Ward, P. A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0033fje · Cited by 86
Self-citationNeutrophil C5a receptor and the outcome in a rat model of sepsis
Guo, R., Riedemann, N. C., Bernacki, K. D., Sarma, V. J., Laudes, I. J., Reuben, J. S., Younkin, E. M., Neff, T. A., Paulauskis, J. D., Zetoune, F. S., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0009fje · Cited by 84
Self-citationAnalysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
Epps, D. E. V., & Chenoweth, D. E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2862 · Cited by 78
C1 Inhibitor Prevents Endotoxin Shock Via a Direct Interaction with Lipopolysaccharide
Liu, D., Cai, S., Gu, X., Scafidi, J., Wu, X. J., & Davis, A. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2594 · Cited by 71
Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme
Cohen, J. (1999) · British Medical Bulletin · doi:10.1258/0007142991902222 · Cited by 71
Hamilton, G., Hofbauer, S., & Hamilton, B. (1992) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549209061344 · Cited by 70
Effects of a new C5a receptor antagonist on C5a‐ and endotoxin‐ induced neutropenia in the rat
Short, A. J., Wong, A. K., Finch, A. M., Haaima, G., Shiels, I. A., Fairlie, D. P., & Taylor, S. M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702338 · Cited by 69
Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function
Chao, T.-H., Ember, J. A., Wang, M., Bayón, Y., Hugli, T. E., & Ye, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9721 · Cited by 68
Schumacher, W. A., Fantone, J. C., Kunkel, S. L., Webb, R. C., & Lucchesi, B. R. (1991) · Inflammation Research · doi:10.1007/bf01988727 · Cited by 68
Buhl, A. M., Osawa, S., & Johnson, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19828 · Cited by 63
Frank, M. M. (2000) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70274-1 · Cited by 61
Gando, S., Nishihira, J., Kobayashi, S., Morimoto, Y., Nanzaki, S., & Kemmotsu, O. (2001) · Intensive Care Medicine · doi:10.1007/s001340000818 · Cited by 60
Structure-Function Relationships of Human C5a and C5aR
Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Padgaonkar, V. A., Younkin, E. M., Guo, R. F., Weber, C. H., Zuiderweg, E. R. P., Zetoune, F. S., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6115 · Cited by 60
Self-citationMolad, Y., HAINES, K. A., Anderson, D. C., et al. (1994) · Biochemical Journal · doi:10.1042/bj2990881 · Cited by 53
Arachidonic acid triggers an oxidative burst in leukocytes
Pompéia, C., Cury‐Boaventura, M. F., & Curi, R. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003001100013 · Cited by 48
Raffetseder, U., Röper, D., Mery, L., Gietz, C., Klos, A., Grötzinger, J., Wollmer, A., Boulay, F., Köhl, J., & Bautsch, W. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00082.x · Cited by 41
Vogt, W. (2000) · Immunobiology · doi:10.1016/s0171-2985(00)80099-6 · Cited by 40
Vogt, W., Zimmermann, B. K., Hesse, D., & Nolte, R. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90106-8 · Cited by 36
Alteration of Chemoattractant Receptor Expression Regulates Human Neutrophil Chemotaxis In Vivo
SEELY, A. J. E., Naud, J.-F., Campisi, G., Giannias, B., Liu, S., DiCarlo, A., Ferri, L. E., L., J. L. P., Tchervenkov, J., & Christou, N. V. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00014 · Cited by 30
Kola, A., Baensch, M., Bautsch, W., et al. (1996) · Immunotechnology · doi:10.1016/1380-2933(96)00425-3 · Cited by 12
Cited by
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
“On the other hand, when the complement-coagulation crosstalk is activated systemically in an uncontrolled manner, as in sepsis, it can lead to life-threatening conditions such as disseminated intravascular coagulatio”
BackgroundAnnane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Harmful molecular mechanisms in sepsis
Rittirsch, D., Flierl, M. A., & Ward, P. A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2402 · Cited by 1,202
Self-citationUpdate on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026
Metadata
- Authors
- Ward, P. A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-02-01
- Volume
- 4
- Issue
- 2
- Pages
- 133-142
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2024242455
- Cited by
- 422
- References
- 99
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.